Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 3/2003

Inhalt (8 Artikel)

Original Article

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

Saroj Basak, Brigitte Birebent, Enkhtsetseg Purev, Rajasekharan Somasundaram, Haruhiko Maruyama, Jan Zaloudik, Rolf Swoboda, Wolfgang Strittmatter, Weiping Li, Albrecht Luckenbach, Hong Song, Jian Li, Katrin Sproesser, Dupont Guerry, Sridar Nair, Koichi Furukawa, Dorothee Herlyn

Original Article

Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells

Manjula Donepudi, Vladimir M. Jovasevic, Pradip Raychaudhuri, Margalit B. Mokyr

Original Article

Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties

Jörg Westermann, Ida J. Körner, Joachim Kopp, Steffen Kurz, Martin Zenke, Bernd Dörken, Antonio Pezzutto

Review

IL-12: a promising adjuvant for cancer vaccination

Johanna E. Portielje, Jan Gratama, Heidi H. van Ojik, Gerrit Stoter, Wim H. Kruit

Original Article

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer

Yukio Iwashita, Kouichirou Tahara, Shigeru Goto, Atsushi Sasaki, Seiichiro Kai, Masataka Seike, Chao-Long Chen, Katsunori Kawano, Seigo Kitano

Original Article

Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2

T. J. P. Spoormakers, W. R. Klein, J. J. L. Jacobs, Th. S. G. A. M. Van Den Ingh, J. W. Koten, W. Den Otter

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.